QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

Vol. 16, Issue 4, 1684-1695, April 2005

This Article Full Text Full Text (PDF) All Versions of this Article: E04-08-0689v1 16/4/1684    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ou, Y.-H. Articles by Shieh, S.-Y. Search for Related Content PubMed PubMed Citation Articles by Ou, Y.-H. Articles by Shieh, S.-Y.

p53 C-Terminal Phosphorylation by CHK1 and CHK2 Participates in the Regulation of DNA-Damage-induced C-Terminal Acetylation

Yi-Hung Ou ^*, Pei-Han Chung ^* , Te-Ping Sun ^* , and Sheau-Yann Shieh ^*

^* Institute of Biomedical Sciences, Academia Sinica, Taipei 115, Taiwan; Graduate Institute of Life Sciences, National Defense Medical Center, Taipei 114, Taiwan

Submitted August 11, 2004; Revised December 14, 2004; Accepted January 8, 2005
Monitoring Editor: Keith Yamamoto

The tumor suppressor protein p53 mediates stress-induced growth arrest or apoptosis and plays a major role in safeguarding genome integrity. In response to DNA damage, p53 can be modified at multiple sites by phosphorylation and acetylation. We report on the characterization of p53 C-terminal phosphorylation by CHK1 and CHK2, two serine/threonine (Ser/Thr) protein kinases, previously implicated in the phosphorylation of the p53 N terminus. Using tryptic phosphopeptide mapping, we have identified six additional CHK1 and CHK2 sites residing in the final 100 amino acids of p53. Phosphorylation of at least three of these sites, Ser366, Ser378, and Thr387, was induced by DNA damage, and the induction at Ser366 and Thr387 was abrogated by small interfering RNA targeting chk1 and chk2. Furthermore, mutation of these phosphorylation sites has a different impact on p53 C-terminal acetylation and on the activation of p53-targeted promoters. Our results demonstrate a possible interplay between p53 C-terminal phosphorylation and acetylation, and they provide an additional mechanism for the control of the activity of p53 by CHK1 and CHK2.

Address correspondence to: Sheau-Yann Shieh (sy88{at}ibms.sinica.edu.tw).

This article has been cited by other articles:

				S. Rajagopalan, A. M. Jaulent, M. Wells, D. B. Veprintsev, and A. R. Fersht 14-3-3 activation of DNA binding of p53 by enhancing its association into tetramers Nucleic Acids Res., October 1, 2008; 36(18): 5983 - 5991. [Abstract] [Full Text] [PDF]

				J.-W. Kim, P. I. Song, M.-H. Jeong, J.-H. An, S.-Y. Lee, S.-M. Jang, K.-H. Song, C. A. Armstrong, and K.-H. Choi TIP60 Represses Transcriptional Activity of p73{beta} via an MDM2-bridged Ternary Complex J. Biol. Chem., July 18, 2008; 283(29): 20077 - 20086. [Abstract] [Full Text] [PDF]

				H. Wang, Y. Zhao, L. Li, M. A. McNutt, L. Wu, S. Lu, Y. Yu, W. Zhou, J. Feng, G. Chai, et al. An ATM- and Rad3-related (ATR) Signaling Pathway and a Phosphorylation-Acetylation Cascade Are Involved in Activation of p53/p21Waf1/Cip1 in Response to 5-Aza-2'-deoxycytidine Treatment J. Biol. Chem., February 1, 2008; 283(5): 2564 - 2574. [Abstract] [Full Text] [PDF]

				K. J.-L. Riley and L. J. Maher III p53 RNA interactions: New clues in an old mystery RNA, November 1, 2007; 13(11): 1825 - 1833. [Abstract] [Full Text] [PDF]

				E. M. Kass, J. Ahn, T. Tanaka, W. A. Freed-Pastor, S. Keezer, and C. Prives Stability of Checkpoint Kinase 2 Is Regulated via Phosphorylation at Serine 456 J. Biol. Chem., October 12, 2007; 282(41): 30311 - 30321. [Abstract] [Full Text] [PDF]

				S. K. Gupta, X. Guo, S. S. Durkin, K. F. Fryrear, M. D. Ward, and O. J. Semmes Human T-cell Leukemia Virus Type 1 Tax Oncoprotein Prevents DNA Damage-induced Chromatin Egress of Hyperphosphorylated Chk2 J. Biol. Chem., October 5, 2007; 282(40): 29431 - 29440. [Abstract] [Full Text] [PDF]

				T. Ishii, H. Sootome, A. J. King, M. Suda, N. Noro, K. Yamashita, and T. Noumi A Robust, Target-Driven, Cell-Based Assay for Checkpoint Kinase 1 Inhibitors J Biomol Screen, September 1, 2007; 12(6): 809 - 817. [Abstract] [PDF]

				A. L. Craig, J. A. Chrystal, J. A. Fraser, N. Sphyris, Y. Lin, B. J. Harrison, M. T. Scott, I. Dornreiter, and T. R. Hupp The MDM2 Ubiquitination Signal in the DNA-Binding Domain of p53 Forms a Docking Site for Calcium Calmodulin Kinase Superfamily Members Mol. Cell. Biol., May 1, 2007; 27(9): 3542 - 3555. [Abstract] [Full Text] [PDF]

				A. Nag, A. Germaniuk-Kurowska, M. Dimri, M. A. Sassack, C. B. Gurumurthy, Q. Gao, G. Dimri, H. Band, and V. Band An Essential Role of Human Ada3 in p53 Acetylation J. Biol. Chem., March 23, 2007; 282(12): 8812 - 8820. [Abstract] [Full Text] [PDF]

				D. P. Stiehl, D. M. Fath, D. Liang, Y. Jiang, and N. Sang Histone Deacetylase Inhibitors Synergize p300 Autoacetylation that Regulates Its Transactivation Activity and Complex Formation Cancer Res., March 1, 2007; 67(5): 2256 - 2264. [Abstract] [Full Text] [PDF]

				M. Lacroix, R.-A. Toillon, and G. Leclercq p53 and breast cancer, an update. Endocr. Relat. Cancer, June 1, 2006; 13(2): 293 - 325. [Abstract] [Full Text] [PDF]

				Y. Zhao, S. Lu, L. Wu, G. Chai, H. Wang, Y. Chen, J. Sun, Y. Yu, W. Zhou, Q. Zheng, et al. Acetylation of p53 at Lysine 373/382 by the Histone Deacetylase Inhibitor Depsipeptide Induces Expression of p21Waf1/Cip1. Mol. Cell. Biol., April 1, 2006; 26(7): 2782 - 2790. [Abstract] [Full Text] [PDF]

				H.-C. Wang, W.-C. Chou, S.-Y. Shieh, and C.-Y. Shen Ataxia Telangiectasia Mutated and Checkpoint Kinase 2 Regulate BRCA1 to Promote the Fidelity of DNA End-Joining Cancer Res., February 1, 2006; 66(3): 1391 - 1400. [Abstract] [Full Text] [PDF]